|View printer-friendly version|
Dr. West’s presentation, “Methodologies for Human Cell Manufacturing from Pluripotent Stem Cells in the Application of Regenerative Medicine,” will be delivered on
- Where are we going wrong? – Contrasting the scale-up manufacturing of adult cells versus pluripotent cells, and analysing the advantages and disadvantages of both
- A look into novel technologies for the reproducible manufacturing of 1st & 2nd generation, highly-identified, purified products derived from pluripotent stem cells
- Case Study – the unique phenotype of pluripotent-stem-cell-derived cells that could improve the process of tissue repair
A copy of Dr. West’s presentation will be made available on the
In addition to the development of therapeutics, BioTime’s research and other activities have resulted, over time, in the creation of other subsidiaries that address other non-therapeutic market opportunities such as cancer diagnostics, drug development and cell research products, and mobile health software applications.
To receive ongoing